John Franklin Fowler serves as Executive at Kezar Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, John Franklin Fowler has executed 9 insider transactions totaling $118.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 10, 2022 involved exercising options for 27,000 shares valued at $24.3K.
John Franklin Fowler currently holds 393,904 shares of Kezar Life Sciences, Inc. (KZR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Franklin Fowler has been a net buyer of KZR stock. They have purchased $118.9K and sold $0 worth of shares.
John Franklin Fowler's most recent insider trade was on Nov 10, 2022, when they sold 27,000 shares at $0.90 per share.
Get notified when new Form 4 filings are submitted
| 7,700 |
| $0.90 |
| Discretionary |
| Dec 31, 2020 | KZR | $14.4K | Option Exercise | 16,000 | $0.90 | Discretionary |
| Feb 4, 2020 | KZR | $100.0K | Purchase | 38,461 | $2.60 | Discretionary |
| Dec 19, 2019 | KZR | $45.0K | Option Exercise | 50,000 | $0.90 | Discretionary |
| Oct 10, 2019 | KZR | $3.2K | Purchase | 1,000 | $3.24 | Discretionary |
| Aug 13, 2019 | KZR | $9.3K | Purchase | 2,000 | $4.66 | Discretionary |
| Aug 9, 2019 | KZR | $3.8K | Purchase | 750 | $5.01 | Discretionary |
| Aug 9, 2019 | KZR | $2.6K | Purchase | 500 | $5.26 | Discretionary |